T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Elevance Health
ELV
|
+$1.16B |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$1.01B |
| 4 |
Royal Caribbean
RCL
|
+$860M |
| 5 |
AET
Aetna Inc
AET
|
+$790M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.76B |
| 2 |
Biogen
BIIB
|
+$1.47B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.26B |
| 4 |
McKesson
MCK
|
+$1.2B |
| 5 |
Sherwin-Williams
SHW
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.75% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Financials | 13.9% |
| 4 | Technology | 11.11% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Enpro
NPO
$7.12B
| $10.1M | ﹤0.01% |
258,698
-559,690
| -68% | -$27.1M |
|
|
LOGM
1302
DELISTED
LogMein, Inc.
LOGM
| $10M | ﹤0.01% |
147,400
+141,400
| +2,357% | +$9.37M |
|
|
KALV
1303
DELISTED
KalVista Pharmaceuticals
KALV
| $9.92M | ﹤0.01% |
198,543
-1,693
| -0.8% | -$144K |
|
|
FCH
1304
DELISTED
Felcor Lodging Trust
FCH
| $9.84M | ﹤0.01% |
1,391,448
+192,200
| +16% | +$1.71M |
|
1305
Generac Holdings
GNRC
$12.8B
| $9.82M | ﹤0.01% |
326,525
+11,740
| +4% | +$377K |
|
1306
Helmerich & Payne
HP
$4.3B
| $9.79M | ﹤0.01% |
207,263
-916,583
| -82% | -$51.9M |
|
|
BLOX
1307
DELISTED
Infoblox Inc
BLOX
| $9.75M | ﹤0.01% |
610,100
+134,040
| +28% | +$2.92M |
|
1308
Ulta Beauty
ULTA
$22.2B
| $9.75M | ﹤0.01% |
59,676
-695
| -1% | -$114K |
|
|
OPLN
1309
Openlane
OPLN
$4.33B
| $9.71M | ﹤0.01% |
722,484
+40,859
| +6% | +$580K |
|
|
DWA
1310
DELISTED
DREAMWORKS ANIMATION SKG INC CL-A
DWA
| $9.69M | ﹤0.01% |
555,370
-702,790
| -56% | -$15.2M |
|
1311
Insulet
PODD
$10.2B
| $9.54M | ﹤0.01% |
368,011
+5,770
| +2% | +$175K |
|
|
PPLI
1312
People Inc
PPLI
$3.01B
| $9.5M | ﹤0.01% |
814,557
-160,588
| -16% | -$2.13M |
|
1313
Zions Bancorporation
ZION
$10.5B
| $9.42M | ﹤0.01% |
342,053
-152,038
| -31% | -$4.51M |
|
1314
Lincoln Electric
LECO
$15.5B
| $9.42M | ﹤0.01% |
179,643
-15,488
| -8% | -$908K |
|
1315
Omnicell
OMCL
$1.72B
| $9.41M | ﹤0.01% |
302,620
+74,700
| +33% | +$2.67M |
|
|
FPRX
1316
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $9.38M | ﹤0.01% |
609,620
-11,190
| -2% | -$240K |
|
1317
Quanta Services
PWR
$101B
| $9.36M | ﹤0.01% |
386,520
-130,510
| -25% | -$3.32M |
|
|
RSE
1318
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
| $9.34M | ﹤0.01% |
+599,144
| New | +$10M |
|
|
ADT
1319
DELISTED
ADT Corp
ADT
| $9.27M | ﹤0.01% |
310,031
-200
| -0.1% | -$6.49K |
|
1320
Fossil Group
FOSL
$330M
| $9.26M | ﹤0.01% |
165,767
-15,404
| -9% | -$976K |
|
|
COHR
1321
DELISTED
Coherent Inc
COHR
| $9.26M | ﹤0.01% |
169,200
-1,300
| -0.8% | -$75.9K |
|
|
HUB.B
1322
DELISTED
HUBBELL INC CL-B
HUB.B
| $9.23M | ﹤0.01% |
108,633
-482,603
| -82% | -$48.2M |
|
|
TGNA
1323
DELISTED
TEGNA Inc
TGNA
| $9.22M | ﹤0.01% |
643,252
+7,813
| +1% | +$132K |
|
1324
Allot
ALLT
$388M
| $9.11M | ﹤0.01% |
1,855,220
+279,450
| +18% | +$1.47M |
|
|
CONE
1325
DELISTED
CyrusOne Inc Common Stock
CONE
| $9.11M | ﹤0.01% |
+278,900
| New | +$8.86M |
|
Similar funds
T. Rowe Price Associates's Q3 2015 Portfolio in Review
As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
- T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
- T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
- T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
- T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
- T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.
Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.